Director Declaration

17 January 2012

BTG plc - Directorship Notification under Listing Rule 9.6.14

Pursuant to the Financial Services Authority Listing Rule 9.6.14(2), BTG plc (the "Company") would like to announce that James O'Shea, who is a non-executive director of the Company, has been appointed as a non-executive director of MAP Pharmaceuticals, Inc. (a US public company whose shares are traded on NASDAQ) with effect from 17 January, 2012

- ends -

Contact for Queries:

Andy Burrows, Director of Investor Relations

+44 (0)20 7575 1741